Myasthenia gravis, seronegative (Q88656): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Em aproximadamente 50% dos pacientes soronegativos para o receptor da acetilcolina com Miastenia Gravis generalizada (MG), nenhum autoanticorpo contra a quinase muscular específica (MuSK) ou contra AChRs pôde ser detectado por métodos de rotina. Neste grupo, autoanticorpos contra a proteína 4 relacionada ao receptor de lipoproteína de baixa densidade (LRP4) foram identificados no soro de vários destes pacientes com uma variação de frequência (7-32%). Existem também pacientes duplamente positivos (com LRP4 e AChR ou MuSK). Anticorpos anti-agrina foram detectados em combinação com autoanticorpos contra MuSK, LRP4 ou AChRs em 10-15% dos pacientes com MG generalizada. | |||||||||||||||
| description / en | description / en | ||||||||||||||
In approximately 50% of the Acetylcholine receptor-seronegative patients with generalised Myasthenia Gravis (MG), no autoantibodies against Muscle-specific kinase (MuSK) or against AChRs could be detected by routine methods. In this group autoantibodies against the low-density lipoprotein receptor-related protein 4 (LRP4) have been identified in several dSN-MG sera with a frequency variation (7-32%). There are also double positive patients (with LRP4 and AChR or MuSK). Anti-agrin antibodies were detected in combination with autoantibodies against MuSK, LRP4, or AChRs in 10-15% of the generalised MG patients. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1979177138 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_1979177138 | |||||||||||||||
| Property / CURIE: CID11:ID_1979177138 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_1979177138 | |||||||||||||||
| Property / Canary Token: dki-india-ID_1979177138 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:59, 15 August 2026
In approximately 50% of the Acetylcholine receptor-seronegative patients with generalised Myasthenia Gravis (MG), no autoantibodies against Muscle-specific kinase (MuSK) or against AChRs could be detected by routine methods. In this group autoantibodies against the low-density lipoprotein receptor-related protein 4 (LRP4) have been identified in several dSN-MG sera with a frequency variation (7-32%). There are also double positive patients (with LRP4 and AChR or MuSK). Anti-agrin antibodies were detected in combination with autoantibodies against MuSK, LRP4, or AChRs in 10-15% of the generalised MG patients.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1979177138 |
||
| English | Myasthenia gravis, seronegative |
In approximately 50% of the Acetylcholine receptor-seronegative patients with generalised Myasthenia Gravis (MG), no autoantibodies against Muscle-specific kinase (MuSK) or against AChRs could be detected by routine methods. In this group autoantibodies against the low-density lipoprotein receptor-related protein 4 (LRP4) have been identified in several dSN-MG sera with a frequency variation (7-32%). There are also double positive patients (with LRP4 and AChR or MuSK). Anti-agrin antibodies were detected in combination with autoantibodies against MuSK, LRP4, or AChRs in 10-15% of the generalised MG patients. |
Statements
CID11:ID_1979177138
0 references
dki-india-ID_1979177138
0 references
Concluído
0 references
13 August 2026
0 references
